CAMBODIAN VENTURES REACHES AGREEMENT TO ACQUIRE INTEREST IN COMPANY SPECIALIZING IN HUMAN AVIAN INFLUENZA SOLUTIONS

Cambodian Ventures Limited (OTC: CMBV), announced today that it has reached a definitive agreement to acquire up to 25% of Montreal based Canadian Bio Med Systems Inc. CBMS will focus on providing education, preventive and protective products, as well as anti-influenza medications. Canadian Bio Med Systems (CBMS) is a company recently formed to provide solutions to the general public in dealing with the containment of the deadly avian influenza A virus (H5N1), also known as "Bird Flu," among humans.

Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=100171)